# Study to Evaluate Solesta for Treatment of Fecal Incontinence

> **NCT01110681** · NA · COMPLETED · sponsor: **Galderma R&D** · enrollment: 115 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DEVICE:** Solesta (Dextranomer in gel of stabilized non-animal hyaluronate)

## Key facts

- **NCT ID:** NCT01110681
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-11
- **Final completion:** 2010-12
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110681, "Study to Evaluate Solesta for Treatment of Fecal Incontinence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01110681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*